Search research articles
Contact Us
Filters
Showing results (191-200 of 509) with videos related to
Page
of 51
Sort By:
Diabetologia
|
September 9, 2025
Evaluating the role of alpha cell dysregulation in the progression to type 2 diabetes using mathematical simulations
Vijaya Subramanian, Arthur S Sherman, Jens J Holst, et al.
Diabetes
|
March 16, 2021
Glucagonostatic Potency of GLP-1 in Patients With Type 2 Diabetes, Patients With Type 1 Diabetes, and Healthy Control Subjects
Jonatan I Bagger, Magnus F G Grøndahl, Asger Lund, et al.
Molecular and Cellular Endocrinology
|
March 23, 2025
Exploring the functional, protective, and transcriptomic effects of GIP on cytokine-exposed human pancreatic islets and EndoC-βH5 cells
Kristine Henriksen, Anne Jørgensen, Simranjeet Kaur, et al.
Peptides
|
November 6, 2019
Glucose-dependent insulinotropic polypeptide (GIP) and cardiovascular disease
Sebastian M Heimbürger, Natasha C Bergmann, Robert Augustin, et al.
Diabetologia
|
February 5, 2013
Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies
S Calanna, M Christensen, J J Holst, et al.
Diabetes Care
|
September 26, 2013
Secretion of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes: systematic review and meta-analysis of clinical studies
Salvatore Calanna, Mikkel Christensen, Jens J Holst, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
October 24, 2015
Cephalic phase secretion of insulin and other enteropancreatic hormones in humans
Simon Veedfald, Astrid Plamboeck, Carolyn F Deacon, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
December 29, 2015
Analysis of large-scale tablet coating: Modeling, simulation and experiments
P Boehling, G Toschkoff, K Knop, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
November 23, 2017
Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response
A Tura, J I Bagger, E Ferrannini, et al.
BMC Health Services Research
|
April 11, 2016
Risk stratification by endocrinologists of patients with type 2 diabetes in a Danish specialised outpatient clinic: a cross-sectional study
Lene Munch, Anne B Arreskov, Michael Sperling, et al.
Page
of 51
Search research articles
Search
Showing results (191-200 of 509) with videos related to
Sort By:
Page
of 51
Diabetologia
|
September 9, 2025
Evaluating the role of alpha cell dysregulation in the progression to type 2 diabetes using mathematical simulations
Vijaya Subramanian, Arthur S Sherman, Jens J Holst, et al.
Diabetes
|
March 16, 2021
Glucagonostatic Potency of GLP-1 in Patients With Type 2 Diabetes, Patients With Type 1 Diabetes, and Healthy Control Subjects
Jonatan I Bagger, Magnus F G Grøndahl, Asger Lund, et al.
Molecular and Cellular Endocrinology
|
March 23, 2025
Exploring the functional, protective, and transcriptomic effects of GIP on cytokine-exposed human pancreatic islets and EndoC-βH5 cells
Kristine Henriksen, Anne Jørgensen, Simranjeet Kaur, et al.
Peptides
|
November 6, 2019
Glucose-dependent insulinotropic polypeptide (GIP) and cardiovascular disease
Sebastian M Heimbürger, Natasha C Bergmann, Robert Augustin, et al.
Diabetologia
|
February 5, 2013
Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies
S Calanna, M Christensen, J J Holst, et al.
Diabetes Care
|
September 26, 2013
Secretion of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes: systematic review and meta-analysis of clinical studies
Salvatore Calanna, Mikkel Christensen, Jens J Holst, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
October 24, 2015
Cephalic phase secretion of insulin and other enteropancreatic hormones in humans
Simon Veedfald, Astrid Plamboeck, Carolyn F Deacon, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
December 29, 2015
Analysis of large-scale tablet coating: Modeling, simulation and experiments
P Boehling, G Toschkoff, K Knop, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
November 23, 2017
Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response
A Tura, J I Bagger, E Ferrannini, et al.
BMC Health Services Research
|
April 11, 2016
Risk stratification by endocrinologists of patients with type 2 diabetes in a Danish specialised outpatient clinic: a cross-sectional study
Lene Munch, Anne B Arreskov, Michael Sperling, et al.
Page
of 51